Prof. Kjetil Taskén, MD, PhD has notified PCI Biotech Holding ASA's Nomination Committee and Board of Directors that he is not able to be a candidate for re-election as Director of PCI Biotech Holding ASA's Board of Directors at the next ordinary general meeting, in May 2018. Prof. Taskén has recently been appointed Head of Institute for Cancer Research at Oslo University Hospital and is therefore not able to continue as a Director of PCI Biotech Holding ASA's Board of Directors. Prof. Taskén has served as a Director since October 2008.